2023 Global Biopharma Resilience Index

The resilience in Biopharma is facing a downturn. The 2023 Global Biopharma Resilience Index from Cytiva offers insights into the industry's current state, spotlighting both strong points and collaborative growth prospects.

We have connected with 1250 biopharma executives across 22 countries to gain insights on how biopharma leaders, academia, and policy-makers can join forces to enhance these opportunities and foster improvement. Dive into our findings around:

Supply chain resilience
Talent pool
R&D ecosystem
Manufacturing agility
Government policy and regulation